Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Quintessent $40M Series AInocras $31M Series BRanked by rounds participated in, from announcements in Jul 19, 2026 – Oct 16, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Quintessent $40M Series AInocras $31M Series BNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Light Links $6M Pre-SeedAurelius Systems $40M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Starcloud $250M Series A+Andromeda Surgical $15M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Powered by People Undisclosed Series BTerminal $20M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Math Magic Undisclosed Series A+PathFinder Undisclosed Pre-SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Twin1 AI $20M SeedFlagler Health $50M Series BNew companies 2 · Follow-on 0
Stages: Undisclosed 2
EcoNomad Solutions £400K Investment and Innovate UK grantVersatile RobotX >£1M Investment and innovation fundingNew companies 2 · Follow-on 0
Stages: Series C+ 2
Castelion $1B Series CNeros Technologies $250M Series CNew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
XBE Undisclosed GrowthHorizon3 $250M Series ENew companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Leal Therapeutics $30M Series AKhartis Therapeutics $50M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
SweGaN $14M Series BMindgard $30M Series ANew companies 2 · Follow-on 0
Stages: Undisclosed 2
Birdsview NOK 40.5M Funding roundVisoid $2.5M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Wispr Flow $280M Series BNatural $30M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Gallos Technologies $50M GrowthMoa Technology £22.2M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Wispr Flow $280M Series BLumilens >$700M Series CNew companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Gravis Robotics $200M Series AThrive Holdings $2B GrowthNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Khartis Therapeutics $50M Series BInfinimmune $75M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Databricks $5B GrowthCandid Health $120M Series D“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.